
News|Articles|October 1, 2003
Abilify (Aripiprazole) Bristol-Myers Squibb/Otsuka
Maintenance therapy for schizophrenia
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
3
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
4
Consolidative radiotherapy shows no survival benefit, added risk in SCLC
5


























